gms | German Medical Science

The ABC Conference: Algae Bioactive Compounds – from research to innovation

The project is funded by Interreg Deutschland-Danmark with means from the European Regional Development Fund.

25. - 26.08.2020, Kiel, Germany (online conference)

Fucoidan: enzymatic purification and modification

Meeting Abstract

  • Maria Dalgaard Mikkelsen - Enzyme Technology, Section for Protein Chemistry and Enzyme Technology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark
  • Thuan Thi Nguyen - Enzyme Technology, Section for Protein Chemistry and Enzyme Technology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark; NhaTrang Institute of Technology Research and Application, Vietnam Academy of Science and Technology, 02 Hung Vuong Street, Nhatrang, Vietnam
  • Hang Thi Thuy Cao - NhaTrang Institute of Technology Research and Application, Vietnam Academy of Science and Technology, 02 Hung Vuong Street, Nhatrang, Vietnam
  • Vy Ha Nguyen Tran - Enzyme Technology, Section for Protein Chemistry and Enzyme Technology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark; NhaTrang Institute of Technology Research and Application, Vietnam Academy of Science and Technology, 02 Hung Vuong Street, Nhatrang, Vietnam
  • Vo Thi Dieu Trang - Enzyme Technology, Section for Protein Chemistry and Enzyme Technology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark; NhaTrang Institute of Technology Research and Application, Vietnam Academy of Science and Technology, 02 Hung Vuong Street, Nhatrang, Vietnam
  • Tran Thi Thanh Van - NhaTrang Institute of Technology Research and Application, Vietnam Academy of Science and Technology, 02 Hung Vuong Street, Nhatrang, Vietnam
  • Anne S. Meyer - Enzyme Technology, Section for Protein Chemistry and Enzyme Technology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark

The FucoSan consortium. The ABC Conference: Algae Bioactive Compounds – from research to innovation. Kiel, 25.-26.08.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. Doc20fucosan07

doi: 10.3205/20fucosan07, urn:nbn:de:0183-20fucosan073

Veröffentlicht: 7. Oktober 2020

© 2020 Mikkelsen et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

The cell walls of brown algae consists of different polysaccharides, which are very different from those in the cell walls of terrestrial plants. They contain fucoidan, a polysaccharide made mainly of sulfated fucose residues. The structural diversity of fucoidan is extremely large due to varieties in monosaccharide compositions, different types of glycosidic linkages and the presence of large numbers of non-carbohydrate substituents, like sulfations but also acetylations. Fucoidans have been extensively studied because of their wide range of biological activities, such as anticoagulant, antithrombotic, anticancer, anti-inflammatory and immunomodulatory [1], [2], [3]. No drug though is currently available, due mainly to the heterogeneity of the fucoidans. The bio-activity of fucoidans depend largely on the structure of the fucoidans. The fucoidan fine structure differs between seaweed species and harvest time, but also the extraction method largely affect the structure. By the means of specific cell-wall-degrading enzymes, including cellulases and alginate lyases, the fucoidan can be released from the cell wall in a gentle way, releasing intact fucoidans [4]. The fucoidans can be further purified by ion-exchange chromatography, obtaining fucoidans of high purity, high molecular weight and high sulfate content [4]. For some applications, fucoidans of low molecular size are desirable. This is normally obtained through treatments with acid, resulting in random degradation and likely also loss of sulfates. In contrast, by using highly specific fucoidan degrading endo-fucoidanases, the fucoidans can be specifically degraded, releasing oligosaccharides with known structure and size distribution. Other fucoidan specific enzymes, including sulfatases can also be used to specifically change the fine structure of fucoidans, enabling structure-function investigations. Fucoidan-modifying enzymes, including fucoidanases and sulfatases, might be the best tool for not only determining the fine structures of fucoidans but also to determine the relationship between fucoidan and the biological activities; hence enzymes might be the best way to enable the production of homogenous fucoidan drugs, both through enzyme-assisted purification and modification.


References

1.
Ale MT, Maruyama H, Tamauchi H, Mikkelsen JD, Meyer AS. Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo. Int J Biol Macromol. 2011;49(3):331-6. DOI: 10.1016/j.ijbiomac.2011.05.009 Externer Link
2.
Ermakova SP, Menshova RV, Anastyuk SD, et al. Structure, chemical and enzymatic modification, and anticancer activity of polysaccharides from the brown alga Turbinaria ornata. J Appl Phycol. 2016;(28):2495–505. DOI: 10.1007/s10811-015-0742-y Externer Link
3.
Lapikova ES, Drozd NN, Tolstenkov AS, et al. Inhibition of thrombin and factor Xa by Fucus evanescens fucoidan and its modified analogs. Bull Exp Biol Med. 2008;146(3):328-33. DOI: 10.1007/s10517-008-0267-3 Externer Link
4.
Nguyen TT, et al. Enzyme-Assisted Fucoidan Extraction from Brown Macroalgae Fucus distichus subsp. evanescens and Saccharina latissima. Mar drugs. 2020;18(6):296. DOI: 10.3390/md18060296 Externer Link